Business Description

Description
Intravenous Infusions Ltd engages in the production of intravenous infusion and small-volume injectables for therapeutic purposes. The product categories are IV fluids, giving sets, and small-volume injectables. The company earns a majority of its revenue from IV fluids. Some of the IV fluids are sodium chloride solutions, dextrose solutions, dextrose saline solutions, and dextran solutions. Small-volume injectables include pethidine injection, magnesium sulphate injection, and quinine injection. Giving sets include plain giving sets, and blood giving sets.

Financial Strength

Name Current Vs Industry Vs History
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
9-Day RSI 100
14-Day RSI 100
6-1 Month Momentum % 25
12-1 Month Momentum % 25

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History

GF Value Rank

Name Current Vs Industry Vs History
PE Ratio N/A
N/A
N/A
PE Ratio without NRI N/A
N/A
N/A

Financials

XGHA:IIL's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Intravenous Infusions Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil GHS)
EPS (TTM) (GHS) 0
Beta 0
Volatility % 25
14-Day RSI 100
14-Day ATR (GHS) 0.000007
20-Day SMA (GHS) 0.05
12-1 Month Momentum % 25
52-Week Range (GHS) 0.04 - 0.05
Shares Outstanding (Mil)

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Intravenous Infusions Ltd Filings

Filing Date Document Date Form
No Filing Data

Intravenous Infusions Ltd Stock Events

Financials Calendars
Event Date Price(GHS)
No Event Data

Intravenous Infusions Ltd Frequently Asked Questions

What is Intravenous Infusions Ltd(XGHA:IIL)'s stock price today?
The current price of XGHA:IIL is GHS0.05. The 52 week high of XGHA:IIL is GHS0.05 and 52 week low is GHS0.04.
When is next earnings date of Intravenous Infusions Ltd(XGHA:IIL)?
The next earnings date of Intravenous Infusions Ltd(XGHA:IIL) is .
Does Intravenous Infusions Ltd(XGHA:IIL) pay dividends? If so, how much?
Intravenous Infusions Ltd(XGHA:IIL) does not pay dividend.

Press Release

Subject Date
No Press Release